AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tandem Diabetes Care Recalls Insulin Pumps Over Malfunction and Safety Risks
ByAinvest
Tuesday, Aug 19, 2025 6:29 pm ET1min read
Tandem Diabetes Care is recalling its t:slim X2 insulin pump due to a potential speaker-related issue that can cause insulin delivery to stop and result in high blood sugar. The company has received 700 adverse event reports, including 59 injuries and no deaths, and will release a software update to enhance early detection of speaker failure. Users can verify if their pump is included in the recall by entering its serial number on the Tandem website.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet